Nothing Special   »   [go: up one dir, main page]

NO324408B1 - Process for the preparation of 4-bromo-aniline derivatives - Google Patents

Process for the preparation of 4-bromo-aniline derivatives Download PDF

Info

Publication number
NO324408B1
NO324408B1 NO20026201A NO20026201A NO324408B1 NO 324408 B1 NO324408 B1 NO 324408B1 NO 20026201 A NO20026201 A NO 20026201A NO 20026201 A NO20026201 A NO 20026201A NO 324408 B1 NO324408 B1 NO 324408B1
Authority
NO
Norway
Prior art keywords
bromo
dihydroisoxazol
pyridine
methylaniline
hours
Prior art date
Application number
NO20026201A
Other languages
Norwegian (no)
Other versions
NO20026201D0 (en
NO20026201L (en
Inventor
Michael Keil
Michael Rack
Joachim Gebhardt
Rene Lochtman
Wolfgang Von Deyn
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of NO20026201D0 publication Critical patent/NO20026201D0/en
Publication of NO20026201L publication Critical patent/NO20026201L/en
Publication of NO324408B1 publication Critical patent/NO324408B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

En fremgangsmåte for fremstilling av 4-bromanilinderivater med formel I hvor: R1 er Ci-C6-alkyl, Ci-C6-halogenalkyl, C-C-alkoksy, C-C-halogenalkoksy, C-C-cykloalkyl, halogen Rer C-C-alkyl, C-C-alkoksy, C-C-cykloalkyl, C-C-alkenyl, cyano eller en heterocyklisk rest er beskrevet.A process for the preparation of 4-bromoaniline derivatives of formula I wherein: R 1 is C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, C 2 -alkoxy, C 2 -haloalkoxy, C 2 -cycloalkyl, halogen R e C 1 -alkyl, C 4 -alkoxy, C -cycloalkyl, CC-alkenyl, cyano or a heterocyclic radical are described.

Description

Foreliggende oppfinnelse tilveiebringer en fremgangsmåte for fremstilling av 4-bromanilinderivater. The present invention provides a method for the production of 4-bromoaniline derivatives.

4-bromanilinderivater er anvendelige forbindelser som blir anvendt som mellomprodukter i kjemisk industri. De er egnet for eksempel for fremstilling av aktive forbindelser anvendt på området avlingsbeskyttelse eller for fremstilling av farmasøytisk aktive forbindelser. WO 99/58509 beskriver for eksempel fremgangsmåter for fremstilling av isoksazolin-3-ylacylbenzener hvor 4-bromanilinderivater blir anvendt som mellomprodukter for fremstilling av herbicid aktive forbindelser. WO 98/31681 beskriver disse aktive forbindelser (2-alkyl-3-(4,5-dihydroisoksazol-3-yl)acylbenzener) som herbicid aktive forbindelser. 4-bromoaniline derivatives are useful compounds that are used as intermediates in the chemical industry. They are suitable, for example, for the production of active compounds used in the field of crop protection or for the production of pharmaceutical active compounds. WO 99/58509 describes, for example, methods for the production of isoxazolin-3-yl acylbenzenes where 4-bromoaniline derivatives are used as intermediates for the production of herbicidally active compounds. WO 98/31681 describes these active compounds (2-alkyl-3-(4,5-dihydroisoxazol-3-yl)acylbenzenes) as herbicidally active compounds.

Det er kjent fra litteraturen at den selektive bromering av aniliner i para stilling er umulig eller bare mulig med vanskelighet (Houben-Weyl 5/4,241,274 ff). Generelt er bromering med elementært brom er ikke selektiv, men ofte forbundet med dannelsen av betraktelige mengder av dibromforbindelser. I henhold til erfaring er selektivitetene for monobrom- til dibromforbindelser i en størrelsesorden på ca. 9:1, dvs. andelen av uønskete dibromforbindelser er ca. 10%. Således ble bare med dyre reagenser, så som tetrabutylammonium-tribromid, forbindelsen 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin, for eksempel oppnådd ved -30 °C i et utbytte på ca. 50% (jf- WO 99/58509). It is known from the literature that the selective bromination of anilines in the para position is impossible or only possible with difficulty (Houben-Weyl 5/4,241,274 ff). In general, bromination with elemental bromine is not selective, but is often associated with the formation of considerable amounts of dibromine compounds. According to experience, the selectivities for monobromo to dibromo compounds are in the order of magnitude of approx. 9:1, i.e. the proportion of undesired dibromo compounds is approx. 10%. Thus, only with expensive reagents, such as tetrabutylammonium tribromide, the compound 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, for example, was obtained at -30 °C in a yield of approx. 50% (see WO 99/58509).

Det er et formål med foreliggende oppfinnelse å tilveiebringe en alternativ It is an object of the present invention to provide an alternative

fremgangsmåte for fremstilling av 4-bromanilinderivater. Framstillingsprosessen beskrevet i WO 99/58509 for 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilinderivatene gir utilfredsstillende utbytter og en utilfredsstillende renhet av produktene. Følgelig har fremgangsmåten beskrevet i WO 99/58509 bare begrenset anvendelse for industriell fremstilling av slike forbindelser. process for the production of 4-bromoaniline derivatives. The production process described in WO 99/58509 for the 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline derivatives gives unsatisfactory yields and an unsatisfactory purity of the products. Consequently, the method described in WO 99/58509 has only limited application for the industrial production of such compounds.

Vi har funnet at dette mål blir nådd ved en fremgangsmåte for fremstilling av 4-bromanilinderivater med formel I We have found that this objective is achieved by a process for the preparation of 4-bromoaniline derivatives of formula I

hvor: where:

R<1> er Ci-C6-alkyl, Ci-C6-halogenalkyl, Ci-C6-alkoksy, d-C6-halogenalkoksy, C3-C8- cykloalkyl* halogen R<1> is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -alkoxy, d -C 6 -haloalkyl, C 3 -C 8 - cycloalkyl* halogen

R<2> erCi-C6-alkyl, Ci-C6-alkoksy, C3-C8-cykloalkyl, C2-C6-alkenyl, cyanoelleren R<2> is C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 3 -C 8 cycloalkyl, C 2 -C 6 alkenyl, cyano or ene

heterocyklisk rest, heterocyclic residue,

hvilken omfatter omsetning av en forbindelse med formel II which involves the reaction of a compound of formula II

hvor R<5> og R<2> er som definert ovenfor med et bromeringsmiddel i et løsningsmiddel inneholdende minst 55 vektprosent pyridin. where R<5> and R<2> are as defined above with a brominating agent in a solvent containing at least 55% by weight of pyridine.

Ved hjelp av fremgangsmåten ifølge oppfinnelsen er det mulig å oppnå anilin-derivatene med formel I i høyere utbytter enn med de tidligere kjente fremstillingsprosesser. Således kan for eksempel forbindelsen 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin oppnås ved fremgangsmåten beskrevet i WO 99/58509 (cf. Eksempel 10 deri) i et utbytte på bare 47%, mens utbyttet ved fremgangsmåten ifølge oppfinnelsen er minst 60%, fortrinnsvis minst 70% eller 80% og spesielt minst 90%. With the aid of the method according to the invention, it is possible to obtain the aniline derivatives of formula I in higher yields than with the previously known production processes. Thus, for example, the compound 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline can be obtained by the method described in WO 99/58509 (cf. Example 10 therein) in a yield of only 47%, while the yield in the method according to the invention is at least 60%, preferably at least 70% or 80% and especially at least 90%.

Videre blir forbindelsene med formel I oppnådd i høyere renhet. Her finner bromeringen sted med høy selektivitet i 4-stillingen til fenylringen. Selektiviteten (forhold av monobrom- til dibromforbindelse) er minst 92:8, spesielt minst 95:5. Overraskende er andelen av urenheter, så som for eksempel dibromider (disse dibromider er derivater med formel I som er substituerte i 5- eller 6-stillingen med et ytterligere brbmatom) sorii er vanskelig å fjerne fra den resulterende reaksjonsblanding eller hvis fjerning krever relativt høye tekniske anstrengelser, mindre enn 5%. Følgelig kan antallet ytterligere rensetrinn for isolering og opparbeidelse av forbindelsene I fremstilt ved fremgangsmåten ifølge oppfinnelsen reduseres. Dette er spesielt fordelaktig for industriell produksjon av forbindelsene I, siden en effektiv og kostnadseffektiv prosess kan frembringes. Furthermore, the compounds of formula I are obtained in higher purity. Here, the bromination takes place with high selectivity in the 4-position of the phenyl ring. The selectivity (ratio of monobromo to dibromo compound) is at least 92:8, especially at least 95:5. Surprisingly, the proportion of impurities, such as for example dibromides (these dibromides are derivatives of formula I which are substituted in the 5- or 6-position with an additional bromide atom) is difficult to remove from the resulting reaction mixture or whose removal requires relatively high technical efforts, less than 5%. Consequently, the number of additional purification steps for isolating and working up the compounds I produced by the method according to the invention can be reduced. This is particularly advantageous for the industrial production of the compounds I, since an efficient and cost-effective process can be produced.

På grunn av høy selektivitet og den lille andell av dibromforbindelser, er det mulig, hvis det passer, å anvende reaksjonsproduktet selv uten ytterligere rensning for neste prosesstrinn for videre omdannelse til egnete sluttprodukter. Due to the high selectivity and the small proportion of dibromo compounds, it is possible, if appropriate, to use the reaction product itself without further purification for the next process step for further conversion to suitable end products.

Cj-Cé-alkyl er en rettkjedet eller forgrenet alkylgruppe som har 1 - 6 karbonatomer, så som for eksempel metyl, etyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl eller n-heksyl; det er foretrukket Ci-C4-alkyl, så som for eksempel metyl, etyl, n-propyl, isopropyl, n-butyl, isobutyl eller tert-butyl. C 1 -C 6 alkyl is a straight chain or branched alkyl group having 1 to 6 carbon atoms, such as, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, n-pentyl or n-hexyl; it is preferably C1-C4-alkyl, such as, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl or tert-butyl.

Ci-C6-Halogenalkyl er en rettkjedet eller forgrenet Ci-C6-alkylgruppe som nevnt ovenfor som er delvis eller fullstendig substituert med fluor, klor, brom og/eller jod, dvs. for eksempel klormetyl, diklormetyl, triklormetyl, fluormetyl, difluormetyl, trifluormetyl, klorfluormetyl, diklorfluormetyl, klordifluormetyl, 2-fluoretyl, 2-kloretyl, 2-brométyl, 2-jodetyl, 2,2-difluoretyl, 2,2,2-trifluoretyl, 2-klor-2-fluoretyl, 2-klor-2,2-difluoretyl, 2,2-diklor-2-fluoretyl, 2,2,2-trikloretyl, pentafluoretyl, 2-fluorpropyl, 3-fluorpropyl, 2,2-difluorpropyl, 2,3-difluorpropyl, 2-klorpropyl, 3-klorpropyl, 2,3-diklorpropyl, 2-brompropyl, 3-brompropyl, 3,3,3-trifluorpropyl, 3,3,3-triklorpropyl, 2,2,3,3,3-pentafluorpropyl, heptafluorpropyl, l-(fluormetyl)-2-fluoretyl, l-(klormetyl)-2-kloretyl, 1- (brommetyl)-2-brometyl, 4-fluorbutyl, 4-klorbutyl, 4-brombutyl, nonafluorbutyl, 5-fluorpentyl, 5-klorpentyl, 5-brompentyl, 5-jodpentyl, undecafluorpentyl, 6-fluorheksyl, 6-klorheksyl, 6-bromheksyl, 6-jodheksyl eller dodecafluorheksyl; Ci-C6 Halogenalkyl is a straight-chain or branched Ci-C6 alkyl group as mentioned above which is partially or completely substituted with fluorine, chlorine, bromine and/or iodine, i.e. for example chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl , chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2 ,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3-fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl, 2-chloropropyl, 3 -chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-pentafluoropropyl, heptafluoropropyl, l-( fluoromethyl)-2-fluoroethyl, l-(chloromethyl)-2-chloroethyl, 1-(bromomethyl)-2-bromomethyl, 4-fluorobutyl, 4-chlorobutyl, 4-bromobutyl, nonafluorobutyl, 5-fluoropentyl, 5-chloropentyl, 5 -bromopentyl, 5-iodopentyl, undecafluoropentyl, 6-fluorohexyl, 6-chlorohexyl, 6-bromohexyl, 6-iodohexyl yl or dodecafluorohexyl;

fortrinnsvis Ci-C4-halogenalkyl, så som klormetyl, diklormetyl, triklormetyl, fluormetyl, difluormetyl, trifluormetyl, chlorfluormetyl, diklorfluormetyl, klordifluormetyl, 2- fluoretyl, 2-kloretyl, 2-brometyl, 2-jodetyl, 2,2-difluoretyl, 2,2,2-trifluoretyl, 2-klor-2-fluoretyl, 2-klor-2,2-difluoretyl, 2,2-diklor-2-fluoretyl, 2,2,2-trikloretyl, pentafluoretyl, 2-fluorpropyl, 3-fluorpropyl, 2,2-difluorpropyl, 2,3-difluorpropyl, preferably C1-C4 haloalkyl, such as chloromethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 2-fluoroethyl, 2-chloroethyl, 2-bromomethyl, 2-iodoethyl, 2,2-difluoroethyl, 2 ,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl, 2-fluoropropyl, 3 -fluoropropyl, 2,2-difluoropropyl, 2,3-difluoropropyl,

2- klorpropyl, 3-klorpropyl, 2,3-diklorpropyl, 2-brompropyl, 3-brompropyl, 3,3,3-trifluorpropyl, 3,3,3-triklorpropyl, 2,2,3,3,3-pentafluorpropyl, heptafluorpropyl, 1- (fluormetyl)-2-fluoretyl, l-(klormetyl)-2-kloretyl, l-(bromrhetyl)-2-brometyl, 4-fluorbutyl, 4-klorbutyl, 4-brbmbutyl eller nonafluorbutyl; 2-chloropropyl, 3-chloropropyl, 2,3-dichloropropyl, 2-bromopropyl, 3-bromopropyl, 3,3,3-trifluoropropyl, 3,3,3-trichloropropyl, 2,2,3,3,3-pentafluoropropyl, heptafluoropropyl, 1-(fluoromethyl)-2-fluoroethyl, 1-(chloromethyl)-2-chloroethyl, 1-(bromoethyl)-2-bromomethyl, 4-fluorobutyl, 4-chlorobutyl, 4-brbmbutyl or nonafluorobutyl;

Cj-C6-alkoksy er en rettkjedet eller forgrenet alkylgruppe som har 1 - 6 karbonatomer, så som for eksempel metoksy, etoksy, n-propyloksy, isopropylbksy, n-butyloksy, isobutyloksy, tert-butyloksy, n-pentyloksy eller n-heksyloksy; fortrinnsvis Ci-C4-alkoksy så som for eksempel metoksy, etoksy, n-propyloksy, n-butyloksy, isobutyloksy eller tert-butyloksy; C1-C6-Alkoxy is a straight-chain or branched alkyl group having 1-6 carbon atoms, such as, for example, methoxy, ethoxy, n-propyloxy, isopropyloxy, n-butyloxy, isobutyloxy, tert-butyloxy, n-pentyloxy or n-hexyloxy; preferably C 1 -C 4 alkoxy such as, for example, methoxy, ethoxy, n-propyloxy, n-butyloxy, isobutyloxy or tert-butyloxy;

Ci-C6-halogenalkoksy ér en rettkjedet eller forgrenet Ci-C6-alkoksygruppe som nevnt ovenfor som er delvis eller fullstendig substituert med fluor, klor, brom og/eller jod, dvs. for eksempel fluormetoksy, difluormetoksy, trifluormetoksy, klordifluormetoksy, bromdifluormetoksy, 2-fluoretoksy, 2-kloretoksy, 2-brometoksy, 2-jodetoksy, 2,2-difluoretoksy, 2,2,2-trifluoretoksy, 2-klor-2-lfuoretoksy, 2-kloir-2,2-difluoretoksy, 2,2-diklor-2-fluoretoksy, 2,2,2-trikloretoksy, pentafluoretoksy, 2-fluorpropoksy, 3- fluorpropoksy, 2-klorpropoksy, 3-klorpropoksy, 2-brompropoksy, 3-brompropoksy, 2,2-difluorpropoksy, 2,3-difluorpropoksy, 2,3-diklorpropoksy, 3,3,3-trifluorpropoksy, 3,3,3-triklorpropoksy, 2,2,3,3-pentafluorpropoksy, heptafluorpropoksy, l-(fluormetyl)-2-fluoretoksy, l-(klormetyl)-2-kloretoksy, l-(brommetyl)-2-brometoksy, 4-fluorbutoksy, 4- klorbutoksy, 4-brombutoksy, nonafluorbutoksy, 5-fluorpentoksy, 5-klorpentoksy, 5- brompentoksy, 5-jodpentoksy, undecafluorpentoksy, 6-fluorheksoksy, 6-klorheksoksy, 6- bromheksoksy, 6-jodheksoksy eller dodecafluorheksoksy; fortrinnsvis Ci-C4-halogenalkoksy, så som fluormetoksy, difluormetoksy, trifluormetoksy, klordifluormetoksy, bromdifluormetoksy, 2-fluoretoksy, 2-kloretoksy, 2-brometoksy, 2-jodetoksy, 2,2-difluoretoksy, 2,2,2-trifluoretoksy, 2-klor-2-fluoretoksy, 2-klor-2,2,difluoretoksy, 2,2-diklor-2-fluoretoksy, 2,2,2-trikloretoksy, pentafluoretoksy, 2- fluorpropoksy, 3-fluorpropoksy, 2-klorpropoksy, 3-klorpropoksy, 2-brompropoksy, 3- brompropoksy, 2,2-difluorpropoksy, 2,3-difluorpropoksy, 2,3-diklorpropoksy, 3,3,3-trifluorpropoksy, 3,3,3-triklorpropoksy, 2,2,3,3-pentafluorpropoksy, heptafluorpropoksy, l-(fluormetyl)-2-fluoretoksy, l-(klormetyl)-2-kloretoksy, l-(brommetyl)-2-brometoksy, 4-fluorbutoksy, 4-klorbutoksy, 4-brombutoksy eller nonafluorbutoksy; Ci-C6-halogeno-alkoxy is a straight-chain or branched Ci-C6-alkoxy group as mentioned above which is partially or completely substituted with fluorine, chlorine, bromine and/or iodine, i.e. for example fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2 -fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2 -dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 2,2-difluoropropoxy, 2,3 -difluoropropoxy, 2,3-dichloropropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, 2,2,3,3-pentafluoropropoxy, heptafluoropropoxy, l-(fluoromethyl)-2-fluoroethoxy, l-( chloromethyl)-2-chloroethoxy, l-(bromomethyl)-2-bromomethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy, nonafluorobutoxy, 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6 -fluorohexoxy, 6- chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy; preferably C 1 -C 4 -halo methoxy, such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorodifluoromethoxy, bromodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromomethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2 -chloro-2-fluoroethoxy, 2-chloro-2,2,difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, 2-fluoropropoxy, 3-fluoropropoxy, 2-chloropropoxy, 3 -chloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2,3-dichloropropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, 2,2,3 ,3-pentafluoropropoxy, heptafluoropropoxy, l-(fluoromethyl)-2-fluoroethoxy, l-(chloromethyl)-2-chloroethoxy, l-(bromomethyl)-2-bromomethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy ;

Ca-Cs-cykloalkyl er en u substituert eller substituert cykloalkylring som har 3 - 8 karbonatomer, så som for eksempel cyklopropyl, cyklobutyl, cyklopentyl, cykloheksyl, cykloheptyl eller cyklooktyl. Egnede substituenter er for eksempel: Q-Ce-alkyl, Ci-C6-alkoksy eller halogen; Ca-Cs-cycloalkyl is an unsubstituted or substituted cycloalkyl ring having 3-8 carbon atoms, such as, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl. Suitable substituents are, for example: C 1 -C 6 alkyl, C 1 -C 6 alkoxy or halogen;

det er foretrukket usubstituert C3-C6-cykloalkyl, så som for eksempel cyklopropyl, cyklopentyl eller cykloheksyl; it is preferably unsubstituted C3-C6 cycloalkyl, such as, for example, cyclopropyl, cyclopentyl or cyclohexyl;

C2-C6-alkenyl er en rettkjedet eller forgrenet alkénylgruppe som har 2-6 karbonatomer, hvor dobbeltbindingen er på bindingspunktet, så som for eksempel etenyl, prop-l-en-1-yl, 1-metylethenyl, buten-l-yl, 1-metylprop-l-en-l-yl, 2-metylprop-l-en-l-yl, penten-1-yl, 1 -metylbut-1 -en-1 -yl, 2-metylbut-1 -en-1 -yl, 3-metylbut-1 -en-1 -yl, 1,2-dimetylprop-1 - en-l-yl, heks-1-en-1-yl, 1-metylpent-l-en-l-yl, 2-metylpent-l-en-l-yl, 3-metylpent-l-en-l-yl, 4-metylpent-l-en-l-yl, 1,2-dimetylbut-l-en-l-yl, 1,3-dimetylbut-l-en-l-yl, 2,3-dimetylbut-1-en-l-yl, 3,3-dimetylbut-l-en-l-yl, 1-etylbut-l-en-l-yl, 2-etylbut-l-en-l-yl eller l-etyl-2-metylprop-l-en-yl; C2-C6-alkenyl is a straight-chain or branched alkenyl group having 2-6 carbon atoms, where the double bond is at the point of attachment, such as ethenyl, prop-l-en-1-yl, 1-methylethenyl, buten-l-yl, 1-methylprop-l-en-l-yl, 2-methylprop-l-en-l-yl, penten-1-yl, 1 -methylbut-1 -en-1 -yl, 2-methylbut-1 -en- 1-yl, 3-methylbut-1-en-1-yl, 1,2-dimethylprop-1-en-l-yl, hex-1-en-1-yl, 1-methylpent-l-en-l- yl, 2-methylpent-l-en-l-yl, 3-methylpent-l-en-l-yl, 4-methylpent-l-en-l-yl, 1,2-dimethylbut-l-en-l- yl, 1,3-dimethylbut-l-en-l-yl, 2,3-dimethylbut-1-en-l-yl, 3,3-dimethylbut-l-en-l-yl, 1-ethylbut-l- en-1-yl, 2-ethylbut-1-en-1-yl or 1-ethyl-2-methylprop-1-en-yl;

Halogen er fluor, klor, brom, spesielt klor eller brom. Halogen is fluorine, chlorine, bromine, especially chlorine or bromine.

"Heterocyklisk ring" er en mettet, umettet eller delvis umettet heterocyklisk gruppe som har 3 - 8 ringatomer og ett, to eller tre oksygen-, svovel- eller nitrogenatomer. Det er foretrukne heterocykliske grupper som inneholder minst ett oksygen og/eller ett "Heterocyclic ring" is a saturated, unsaturated or partially unsaturated heterocyclic group having 3 - 8 ring atoms and one, two or three oxygen, sulfur or nitrogen atoms. Preferred are heterocyclic groups containing at least one oxygen and/or one

nitrogenatom. Videre de heterocykliske grupper foretrukket som har 5 eller 6 ringatomer. Den heterocykliske gruppen kan være bundet til fenylringen på hvilken som helst punkt i den heterocykliske gruppen, for eksempel gjennom et heterocylisk nitrogenringatom eller et karbonringatom. De heterocykliske gruppene er usubstituerte eller mono-, di- eller trisubstituerte. Egnede substituenter er rester som er kjemisk inerte under de valgte reaksjonsbetingelser, så som for eksempel Ci-C6-alkyl, Ci-C6-alkoksy eller halogen. Egnete heterocykliske ringer i sammenheng med foreliggende oppfinnelse er for eksempel de følgende heterocykliske grupper: pyrrolyl, pyrazolyl, imidazolyl, oksazolyl, isoksazolyl, tiazolyl, tiadiazolyl, piperidinyl, morfolinyl, oksazinyl, isoksazolinyl, nitrogen atom. Furthermore, the heterocyclic groups preferred which have 5 or 6 ring atoms. The heterocyclic group may be attached to the phenyl ring at any point in the heterocyclic group, for example through a heterocyclic nitrogen ring atom or a carbon ring atom. The heterocyclic groups are unsubstituted or mono-, di- or tri-substituted. Suitable substituents are residues which are chemically inert under the chosen reaction conditions, such as, for example, C1-C6 alkyl, C1-C6 alkoxy or halogen. Suitable heterocyclic rings in the context of the present invention are, for example, the following heterocyclic groups: pyrrolyl, pyrazolyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, thiadiazolyl, piperidinyl, morpholinyl, oxazinyl, isoxazolinyl,

isoksazolidinyl, etc. De følgende heterocykliske grupper er foretrukket: isoksazolyl, isoksazolinyl eller isoksazolidinyl, spesielt 4,5-dihydroisoksazol-3-yl eller 4,5-dihydroisoksazol-5-yl. isoxazolidinyl, etc. The following heterocyclic groups are preferred: isoxazolyl, isoxazolinyl or isoxazolidinyl, especially 4,5-dihydroisoxazol-3-yl or 4,5-dihydroisoxazol-5-yl.

Fremgangsmåten ifølge oppfinnelsen er fortrinnsvis egnet for fremstilling av forbindelser med formel I hvor substituentene er som definert nedenfor: The method according to the invention is preferably suitable for the preparation of compounds of formula I where the substituents are as defined below:

R<1> erCi-C6-alkyl,Ci-C6-alkoksy,C3-C8-cykloalkyl, halogen, R<1> is C1-C6-alkyl, C1-C6-alkoxy, C3-C8-cycloalkyl, halogen,

R<2> er Ci-C6-alkyl, Ci-C6-alkoksy, C3-C8-cykloalkyl, cyano eller en heterocyklisk rest. R<2> is C1-C6 alkyl, C1-C6 alkoxy, C3-C8 cycloalkyl, cyano or a heterocyclic radical.

Fremgangsmåten ifølge oppfinnelsen er videre fortrinnsvis egnet for fremstilling av de følgende forbindelser med formel I: 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylånilin, The method according to the invention is furthermore preferably suitable for the production of the following compounds of formula I: 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline,

4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-etylanilin, 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-ethylaniline,

4-brom-2-(4,5-dihydroisoksazol-3-yl-)3-metoksyanilin, 4-bromo-2-(4,5-dihydroisoxazol-3-yl-)3-methoxyaniline,

4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-etoksyanilin, 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-ethoxyaniline,

4-brom-2-(3-metyl-4,5-dihydroisoksazol-5-yl)-3-metylanilin, 4-bromo-2-(3-methyl-4,5-dihydroisoxazol-5-yl)-3-methylaniline,

4-brom-2-(3-metyl-4,5-dihydroisoksazol-5-yl)-3-etylanilin, 4-bromo-2-(3-methyl-4,5-dihydroisoxazol-5-yl)-3-ethylaniline,

4-brom-2-(3-metyl-4,5-dihydroisoksazol-5-yl-)3-metoksyanilin, 4-brom-2-(3-metyl-4,5-dihydroisoksazol-5-yl)-3-etoksyanilin, 4-brom-2-(isoksazol-3-yl)-3-metylanilin, 4-bromo-2-(3-methyl-4,5-dihydroisoxazol-5-yl-)3-methoxyaniline, 4-bromo-2-(3-methyl-4,5-dihydroisoxazol-5-yl)-3- ethoxyaniline, 4-bromo-2-(isoxazol-3-yl)-3-methylaniline,

4-brom-2-(isoksazol-3-yl)-3-etylanilin, 4-bromo-2-(isoxazol-3-yl)-3-ethylaniline,

4-brom-2-(isoksazol-3-yl)-3-metoksyanilin, 4-bromo-2-(isoxazol-3-yl)-3-methoxyaniline,

4-brom-2-(isoksazol-3-yl)-3-etoksyanilin, 4-bromo-2-(isoxazol-3-yl)-3-ethoxyaniline,

4-brom-2-(5-metylisoksazol-3-yl)-3-metylanilin, 4-brom-2-(5-metylisoksazol-3-yl)-3-etylanilin, 4-bromo-2-(5-methylisoxazol-3-yl)-3-methylaniline, 4-bromo-2-(5-methylisoxazol-3-yl)-3-ethylaniline,

4-brom-2-(5-metylisoksazol-3-yl-)3-metoksyanilin, 4-bromo-2-(5-methylisoxazol-3-yl-)3-methoxyaniline,

4-brom-2-(5-metylisoksazol-3-yl)-3-etoksyanilin, 4-bromo-2-(5-methylisoxazol-3-yl)-3-ethoxyaniline,

4-brom-2-cyano-3-metylanilin, 4-bromo-2-cyano-3-methylaniline,

4-brom-2-cyano-3-metoksyanilin. 4-Bromo-2-cyano-3-methoxyaniline.

Reaksjonen til forbindelsene II med et bromeringsmiddel blir fortrinnsvis utført ved de følgende prosesstrinn: Ifølge oppfinnelsen blir reaksjonen utført i løsningsmidlet pyridin eller i løsningsmiddelblandinger omfattende minst 55 vekt%, fortrinnsvis 80 vekt% av pyridin. I tilfellet av løsningsmiddelblandinger er egnet ytterligere løsningsmidler i blandingen med pyridin er for eksempel alkoholer, så som metanol eller etanol, spesielt metanol; estere, så som etylacetat eller butylacetat, spesielt etylacetat eller butylacetat; amider, så som for eksempel N,N-dimetylformamid eller N,N-dimetylacetamid; eller vann. The reaction of compounds II with a brominating agent is preferably carried out in the following process steps: According to the invention, the reaction is carried out in the solvent pyridine or in solvent mixtures comprising at least 55% by weight, preferably 80% by weight of pyridine. In the case of solvent mixtures, suitable further solvents in the mixture with pyridine are, for example, alcohols, such as methanol or ethanol, especially methanol; esters, such as ethyl acetate or butyl acetate, especially ethyl acetate or butyl acetate; amides, such as for example N,N-dimethylformamide or N,N-dimethylacetamide; or water.

Først blir forbindelsen II satt til pyridin eller en pyridin-inneholdende løsningsmiddelblanding som løsning eller suspensjon. Bromeringsmidlet blir deretter tilsatt over et tidsrom på 5 minutter - 5 timer. Bromeringsmidlet blir tilsatt enten direkte, dvs. uten løsningsmiddel eller sammen med et egnet løsningsmiddel. First, compound II is added to pyridine or a pyridine-containing solvent mixture as a solution or suspension. The brominating agent is then added over a period of 5 minutes - 5 hours. The brominating agent is added either directly, i.e. without solvent or together with a suitable solvent.

Foretrukne bromeringsmidler er elementært brom eller en blanding av HBr og hydrogenperoksyd. I tilfellet brom blir bromet fortrinnsvis tilsatt sammen med et egnet løsningsmiddel, så som for eksempel pyridin under dannelse av pyridiniumperbromid. I dette tilfellet blir én spesielt høy selektivitet i forholdet av monobrom- til dibromforbindelse oppnådd. Preferred brominating agents are elemental bromine or a mixture of HBr and hydrogen peroxide. In the case of bromine, the bromine is preferably added together with a suitable solvent, such as, for example, pyridine to form pyridinium perbromide. In this case, a particularly high selectivity in the ratio of monobromo to dibromo compound is achieved.

I en foretrukket utførelsesform av fremgangsmåten blir bromeringensmiddel og forbindelsen II blir anvendt i et molart forhold fra 1:1 til 2:1. Bromeringsmidlet blir fortrinnsvis anvendt i ekvimolare mengder eller i et svakt overskudd. In a preferred embodiment of the method, the brominating agent and the compound II are used in a molar ratio of from 1:1 to 2:1. The brominating agent is preferably used in equimolar amounts or in a slight excess.

Reaksjonen blir utført ved temperaturer på fra 20 °C til kokepunktet for løsningsmidlet, fortrinnsvis i området fra 60 °C til 85 °C. I en ytterligere foretrukket utførelsesform blir reaksjonen utført ved temperaturer fra 50°C til 100°C, fortrinnsvis i området fra 80°C til 100°C, med spesiell preferanse ved ca. 100°C. The reaction is carried out at temperatures of from 20 °C to the boiling point of the solvent, preferably in the range from 60 °C to 85 °C. In a further preferred embodiment, the reaction is carried out at temperatures from 50°C to 100°C, preferably in the range from 80°C to 100°C, with particular preference at approx. 100°C.

Reaksjonstiden er 1 - 24 timer, fortrinnsvis 2-12 timer, spesielt 5-8 timer. I en ytterligere foretrukket utførelsesform er reaksjonstiden 30 min -10 timer, fortrinnsvis The reaction time is 1-24 hours, preferably 2-12 hours, especially 5-8 hours. In a further preferred embodiment, the reaction time is preferably 30 minutes to 10 hours

30 min - 5 timer. 30 min - 5 hours.

Hvis bromeringsmidlet som blir anvendt er en blanding av HBr og hydrogenperoksyd, blir bromeringsmidlet satt til løsningen av II over et tidsrom på fortrinnsvis fra 10 minutter til 3 timer. Molforholdet av HBr til forbindelsen II er fortrinnsvis i området fra 1:1 til 1,5:1. Tilsetningen blir utført ved temperaturer på 0 - 50 °C, fortrinnsvis 20 - 40°C. Hydrogenperoksydet blir deretter tilsatt. Molforholdet av H2O2 til HBr er fra 1:1 til 1,5:1. Tilsetningen blir utført ved temperaturer på fra 10 °C til kokepunktet for løsningsmidlet, fortrinnsvis fra 50°C til 120°C, med preferanse fra 80°C til 100°C, med spesiell preferanse ved ca. 100°C; i en ytterligere foretrukket utførelsesform blir tilsetningen fortrinnsvis utført ved fra 60°C til 85°C. Løsningen blir deretter rørt i et tidsrom på 10 min - 36 timer, fortrinnsvis 10 min - 8 timer, i en ytterligere utførelsesform blir løsningen rørt i et tidsrom på 1 - 36 timer, fortrinnsvis 2-8 timer. I en ytterligere utførelsesform blir løsningen rørt i et tidsrom fra 10 min til 3 timer, fortrinnsvis fra 10 min til 2 timer. Deretter blir produktet opparbeidet og renset. For dette formål løsningen blir konsentrert. Råproduktet blir If the brominating agent used is a mixture of HBr and hydrogen peroxide, the brominating agent is added to the solution of II over a period of preferably from 10 minutes to 3 hours. The molar ratio of HBr to compound II is preferably in the range from 1:1 to 1.5:1. The addition is carried out at temperatures of 0 - 50 °C, preferably 20 - 40 °C. The hydrogen peroxide is then added. The molar ratio of H2O2 to HBr is from 1:1 to 1.5:1. The addition is carried out at temperatures of from 10°C to the boiling point of the solvent, preferably from 50°C to 120°C, with preference from 80°C to 100°C, with particular preference at approx. 100°C; in a further preferred embodiment, the addition is preferably carried out at from 60°C to 85°C. The solution is then stirred for a period of 10 min - 36 hours, preferably 10 min - 8 hours, in a further embodiment the solution is stirred for a period of 1 - 36 hours, preferably 2 - 8 hours. In a further embodiment, the solution is stirred for a period of from 10 min to 3 hours, preferably from 10 min to 2 hours. The product is then processed and cleaned. For this purpose, the solution is concentrated. The raw product becomes

oppløst i et egnet løsningsmiddel, fortrinnsvis pyridin eller en løsningsmiddelblanding omfattende minst 50% pyridin, og vann blir tilsatt. Filtrering og vasking av residuet etter krystallisering ved anvendelse av et egnet løsningsmiddel (for eksempel vann) gir produktet i godt utbytte og høy renhet. dissolved in a suitable solvent, preferably pyridine or a solvent mixture comprising at least 50% pyridine, and water is added. Filtration and washing of the residue after crystallization using a suitable solvent (for example water) gives the product in good yield and high purity.

Imidlertid er det også mulig å ta opp råproduktet i dimetyldisulfid og vaske produktet med vann og/eller vandig natriumhydroksydløsning. Den organiske løsningen kan deretter anvendes for påfølgende trinn. However, it is also possible to take up the crude product in dimethyl disulfide and wash the product with water and/or aqueous sodium hydroxide solution. The organic solution can then be used for subsequent steps.

I en foretrukket utførelsesform blir forbindelsen med formel II først satt til pyridin eller en blanding av pyridin og vann. I det sistnevnte tilfellet er forholdet av pyridin til vann i området fra 80 til 98 vekt% til 20 til 5 vekt%, fortrinnsvis i et område fra 90 til 95 vekt% til 10 til 5 vekt%. In a preferred embodiment, the compound of formula II is first added to pyridine or a mixture of pyridine and water. In the latter case, the ratio of pyridine to water is in the range from 80 to 98% by weight to 20 to 5% by weight, preferably in a range from 90 to 95% by weight to 10 to 5% by weight.

Forholdet av forbindelsen med formel II til pyridin eller pyridin/vann blir valgt slik at en 5 - 25% sterk løsning, fortrinnsvis en 10 - 15% sterk løsning, blir dannet. Over 0,8 til 1,1 molekvivalenter, fortrinnsvis 0,9 til 1,0 molekvivalenter, av HBr blir deretter satt til den resulterende løsning. Vannet blir fjernet ved azeotrop destillering og hydrogenperoksyd blir satt til løsningen som holdes over et tidsrom på 1 - 3 timer, fortrinnsvis 1,5 - 2,5 timer, på 50 - 120°C, fortrinnsvis 80 - 110°C, spesielt på ca. 100°C. Hydrogenperoksydet blir vanligvis anvendt i en 20% sterk til 50% sterk, fortrinnsvis 30 til 50% sterk, vandig løsning. The ratio of the compound of formula II to pyridine or pyridine/water is chosen so that a 5-25% strong solution, preferably a 10-15% strong solution, is formed. Over 0.8 to 1.1 molar equivalents, preferably 0.9 to 1.0 molar equivalents, of HBr is then added to the resulting solution. The water is removed by azeotropic distillation and hydrogen peroxide is added to the solution which is kept over a period of 1 - 3 hours, preferably 1.5 - 2.5 hours, at 50 - 120°C, preferably 80 - 110°C, especially at approx. . 100°C. The hydrogen peroxide is usually used in a 20% to 50% strength, preferably 30 to 50% strength, aqueous solution.

Blandingen blir deretter rørt i ca. 10 min til 2 timer, fortrinnsvis 30 min til 1 time. The mixture is then stirred for approx. 10 min to 2 hours, preferably 30 min to 1 hour.

Dette blir fulgt av opparbeidelse av produktet. For dette formål blir reaksjonsløsningen avkjølt til omtrent romtemperatur og om nødvendig vasket med vandig natriumsulfittløsning, og den organiske fasen blir konsentrert. Det resulterende produkt kan anvendes uten ytterligere rensning for påfølgende reaksjoner. Imidlertid er det også mulig å ta opp residuet i dimetyldisulfid, å vaske den resulterende løsning med vann eller vandig natriumhydroksydløsning og å anvende den resulterende organiske fasen for påfølgende reaksjoner. This is followed by processing of the product. For this purpose, the reaction solution is cooled to about room temperature and, if necessary, washed with aqueous sodium sulfite solution, and the organic phase is concentrated. The resulting product can be used without further purification for subsequent reactions. However, it is also possible to take up the residue in dimethyl disulfide, to wash the resulting solution with water or aqueous sodium hydroxide solution and to use the resulting organic phase for subsequent reactions.

I en ytterligere utførelsesform er det mulig å tilsette HBr til pyridinet som, hvis det passer, inneholder opptil 10% av vann og deretter fjerne vannet azeotropt. Forbindelsen med formel II blir deretter oppløst i reaksjonsblandingen, og hydrogenperoksyd blir tilsatt dråpevis. Både det kvantitative forhold av substansene som blir anvendt og tids- og temperaturbetingelser svarer til betingelsene nevnt ovenfor. In a further embodiment, it is possible to add HBr to the pyridine which, if appropriate, contains up to 10% of water and then remove the water azeotropically. The compound of formula II is then dissolved in the reaction mixture, and hydrogen peroxide is added dropwise. Both the quantitative ratio of the substances used and the time and temperature conditions correspond to the conditions mentioned above.

I en ytterligere utførelsesform er det også mulig å anvende pyridinium-hydrobromid istedenfor pyridin og HBr. In a further embodiment, it is also possible to use pyridinium hydrobromide instead of pyridine and HBr.

Hvis bromeringsmidlet som blir anvendt er elementært brom, blir bromeringsmidlet fortrinnsvis satt til løsningen av II litt av gangen eller kontinuerlig over et tidsrom på fra ca. 30 minutter til 6 timer. Molforholdet av brom til forbindelsen II er fortrinnsvis i området fra 1:1 til 1,5:1. Tilsetningen blir utført ved temperaturer på 0 - 50 °C, fortrinnsvis ved romtemperatur. Løsningen blir deretter rørt i et tidsrom på 1 - 24 timer, fortrinnsvis 2-8 timer. Deretter blir produktet opparbeidet og renset. For dette formål blir løsningen konsentrert og råproduktet blir oppløst i et egnet løsningsmiddel, fortrinnsvis pyridin eller en løsningsmiddelblanding omfattende minst 50% pyridin, og blandet med vann. Filtrering og vasking av residuet etter krystallisering ved anvendelse av et egnet løsningsmiddel (for eksempel vann) gir produktet i godt utbytte og høy renhet. If the brominating agent used is elemental bromine, the brominating agent is preferably added to the solution of II a little at a time or continuously over a period of from approx. 30 minutes to 6 hours. The molar ratio of bromine to compound II is preferably in the range from 1:1 to 1.5:1. The addition is carried out at temperatures of 0 - 50 °C, preferably at room temperature. The solution is then stirred for a period of 1-24 hours, preferably 2-8 hours. The product is then processed and cleaned. For this purpose, the solution is concentrated and the crude product is dissolved in a suitable solvent, preferably pyridine or a solvent mixture comprising at least 50% pyridine, and mixed with water. Filtration and washing of the residue after crystallization using a suitable solvent (for example water) gives the product in good yield and high purity.

Videre kan produktet også oppnås fra reaksjonsløsningen ved ekstraksjon. For dette formål blir reaksjonsløsningen først konsentrert, og residuet blir tatt opp i et egnet løsningsmiddel eller løsnirigsmiddelblanding, idet komponentene velges for eksempel fra vann, etylacetat og dimetyldisulfid (DMDS), spesielt vann, etylacetat, vann/etylacetat eller vann/DMDS. Egnet for ekstraksjonen er ikke-vannblandbare løsningsmidler eller de tilsvarende løsningsmiddelblandinger, så som for eksempel etylacetat, butylacetat, toluen eller metyl-tert-butyleter (MTBE). Konsentrasjon av løsningen gir produktet i god utbytte og høy renhet. Furthermore, the product can also be obtained from the reaction solution by extraction. For this purpose, the reaction solution is first concentrated, and the residue is taken up in a suitable solvent or solvent mixture, the components being selected for example from water, ethyl acetate and dimethyl disulfide (DMDS), especially water, ethyl acetate, water/ethyl acetate or water/DMDS. Suitable for the extraction are non-water-miscible solvents or the corresponding solvent mixtures, such as, for example, ethyl acetate, butyl acetate, toluene or methyl tert-butyl ether (MTBE). Concentration of the solution gives the product in good yield and high purity.

Råproduktet blir renset enten ved vasking av det oppnådde residuet eller ved krystallisering; Egnet for vasking er for eksempel vann og vandige løsningsmidler. Egnet, for omkrystallisering er for eksempel toluen og benzen. The crude product is purified either by washing the obtained residue or by crystallization; Suitable for washing are, for example, water and aqueous solvents. Suitable for recrystallization are, for example, toluene and benzene.

I prinsippet kan i sammenheng med videre reaksjon for fremstilling av aktive forbindelser råproduktet som oppnås også anvendes for neste reaksjonstrinn uten ytterligere rensning av reaksjonsløsningen. For dette formål kan reaksjonsløsningen som inneholder forbindelsene med formel I fortynnes med ytterligere løsningsmidler og således anvendes som en rå løsning for det neste prosesstrinn. Alternativt er det også mulig å konsentrere reaksjonsløsningen og overføre det resulterende residuet direkte eller som en smelte tii neste prosesstrinn. In principle, in the context of further reaction for the production of active compounds, the crude product obtained can also be used for the next reaction step without further purification of the reaction solution. For this purpose, the reaction solution containing the compounds of formula I can be diluted with further solvents and thus used as a crude solution for the next process step. Alternatively, it is also possible to concentrate the reaction solution and transfer the resulting residue directly or as a melt to the next process step.

Forbindelsene med formel II som skal anvendes som utgangsmaterialer er kjent fra litteraturen og/eller er kommersielt tilgjengelige. De kan fremstilles ved prosesser som er kjente per se, så som for eksempel beskrevet mer detaljert i WO 98/31681; eller WO 99/58509. The compounds of formula II to be used as starting materials are known from the literature and/or are commercially available. They can be produced by processes known per se, such as, for example, described in more detail in WO 98/31681; or WO 99/58509.

Oppfinnelsen er illustrert mer detaljert i utførelseseksemplene nedenfor. The invention is illustrated in more detail in the embodiment examples below.

Eksempel 1 Example 1

4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin 4-Bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline

Bromeringsmiddel: HBT/ H2O2 Brominating agent: HBT/ H2O2

100,5 g 2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin blir først satt til 2000 g pyridin, og 98,2 g HBr blir tilsatt dråpevis ved 20-35 °C. Ved 78-84 °C blir 64,6 g hydrogenperoksyd deretter tilsatt dråpevis over 0,5 timer. Blandingen blir rørt ved 25°C i ytterligere 12 timer og deretter konsentrert inntil en oljeaktig rest er tilbake. Råproduktet blir oppløst ved 50°C i 100 ml pyridin og blandet med 1000 ml vann. Blandingen blir rørt ved 0°C i 1 time og deretter filtrert fra, og filterkaken blir vasket to ganger med 200 ml vann og tørket. 100.5 g of 2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline is first added to 2000 g of pyridine, and 98.2 g of HBr is added dropwise at 20-35 °C. At 78-84 °C, 64.6 g of hydrogen peroxide are then added dropwise over 0.5 hours. The mixture is stirred at 25°C for a further 12 hours and then concentrated until an oily residue remains. The crude product is dissolved at 50°C in 100 ml of pyridine and mixed with 1000 ml of water. The mixture is stirred at 0°C for 1 hour and then filtered off, and the filter cake is washed twice with 200 ml of water and dried.

Dette gir 141 g (utbytte: 92%) av et gult, fast stoff (HPLC: 94,6% av 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin, 1,8% av 6-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin, 3,4% av 4,6-dibrom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin). This gives 141 g (yield: 92%) of a yellow solid (HPLC: 94.6% of 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 1.8% of 6-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 3.4% of 4,6-dibromo-2-(4,5-dihydroisoxazol-3-yl)-3- methylaniline).

Eksempel 2 Example 2

4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin 4-Bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline

Bromeringsmiddel: brom Brominating agent: bromine

100 g 2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin blir først satt til 1000 g pyridin, og en løsning av tilsammen 96,19 g brom i 1000 g pyridin blir tilsatt dråpevis ved 20°C i fem nyfremstilte porsjoner over 3 timer. Blandingen blir rørt i ytterligere 12 timer. Pyridin blir avdestillert ved 150 mbar og en badtemperatur på 75°C. Residuet blir oppløst i 21 vann og ekstrahert gjentatte ganger med 250 ml etylacetat i hvert tilfelle. Konsentrasjon gir 122,1 g produkt (utbytte 81,6%; GC: 93,2% av 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin, 2,7% av 6-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin, 4,1% av 4,6-dibrom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin). 100 g of 2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline is first added to 1000 g of pyridine, and a solution of a total of 96.19 g of bromine in 1000 g of pyridine is added dropwise at 20°C for five freshly prepared portions over 3 hours. The mixture is stirred for a further 12 hours. Pyridine is distilled off at 150 mbar and a bath temperature of 75°C. The residue is dissolved in water and extracted repeatedly with 250 ml of ethyl acetate in each case. Concentration gives 122.1 g of product (yield 81.6%; GC: 93.2% of 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 2.7% of 6- bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 4.1% of 4,6-dibromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline).

Eksempel 3 Example 3

4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin 4-Bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline

Bromeringsmiddel: brom Brominating agent: bromine

5 g forbindelsen 2-(4,5-dihydroisoksazoi-3-yl)-3-metylanirin blir først satt til 50 g pyridin, og en løsning av tilsammen 4,89 g brom i 50 g pyridin (blandingen må fremstilles ved 0°C) blir tilsatt dråpevis ved 20°C over 5 timer. Blandingen blir rørt ved 25°C i ytterligere 12 timer. Satsen blir hellet i 250 ml vann og ekstrahert tre ganger med 100 ml MTBE i hvert tilfelle. De samlede organiske faser blir vasket to ganger med 100 ml vann i hvert tilfelle, tørket over natriumsulfat og inndampet. 5 g of the compound 2-(4,5-dihydroisoxazoi-3-yl)-3-methylanirine is first added to 50 g of pyridine, and a solution of a total of 4.89 g of bromine in 50 g of pyridine (the mixture must be prepared at 0°C ) is added dropwise at 20°C over 5 hours. The mixture is stirred at 25°C for a further 12 hours. The batch is poured into 250 ml of water and extracted three times with 100 ml of MTBE in each case. The combined organic phases are washed twice with 100 ml of water in each case, dried over sodium sulfate and evaporated.

Dette gir 6,0 g produkt (utbytte 79,8%; 94,3% av 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3- metylanilin, 1,8% av 6-brom-2-(4,5rdihydroisoksazol-3-yl)-3-metylanilin, 3,5% av 4,6-dibrom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin). This gives 6.0 g of product (yield 79.8%; 94.3% of 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 1.8% of 6-bromo- 2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline, 3.5% of 4,6-dibromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline).

Eksempel 4 Example 4

4- brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline

Bromeringsmiddel: HBr, H2O2Brominating agent: HBr, H2O2

500,0 g 2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin blir først satt til 4500 g pyridin, og ved 25 - 35°C blir 467,4 g 47% sterk HBr tilsatt dråpevis. Under tilbakeløp blir vannet avdestillert azeotropt ved atmosfærisk trykk. Ved 100°C blir 199,2 g 50% styrke H202 deretter tilsatt dråpevis over et tidsrom på 2 timer. Reaksjonsblandingen blir rørt i en time til og deretter avkjølt til romtemperatur og vasket med natriumsulfittløsning, og løsningsmidlet blir så avdestillert (T<100°C). Residuet blir tatt opp i 3 220 g dimetyldisulfid og ved 60°C vasket med 1500 g vann. Den resulterende løsning blir anvendt for den påfølgende reaksjon. 500.0 g of 2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline is first added to 4500 g of pyridine, and at 25 - 35°C 467.4 g of 47% strong HBr is added dropwise. During reflux, the water is distilled off azeotropically at atmospheric pressure. At 100°C, 199.2 g of 50% strength H 2 O 2 is then added dropwise over a period of 2 hours. The reaction mixture is stirred for another hour and then cooled to room temperature and washed with sodium sulphite solution, and the solvent is then distilled off (T<100°C). The residue is taken up in 3,220 g of dimethyl disulphide and washed at 60°C with 1,500 g of water. The resulting solution is used for the subsequent reaction.

Dette gir ca. 83% av det ønskede produkt. This gives approx. 83% of the desired product.

Claims (10)

1. Fremgangsmåte for fremstilling av 4-bromanilinderivater med formel I hvor: R<1> er Ci-C6-alkyl, Ci-C6-halogenalkyl, Ci-C6-alkoksy, Ci-C6-halogenalkoksyi Cs-Cs-cykloalkyl, halogen R<2> er Ci-C6-alkyl, C]-C6-alkoksy, C3-C8-cykloalkyl, C2-C6-alkenyl, cyano eller en heterocyklisk rest, hvilken omfatter omsetning av en forbindelse med formel II hvor R<1> og R<2> er som definert ovenfor med et bromeringsmiddel i et løsningsmiddel inneholdende minst 55 vektprosent pyridin.1. Process for the preparation of 4-bromoaniline derivatives of formula I where: R<1> is C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 alkoxy, C1-C6 haloalkyl Cs-Cs-cycloalkyl, halogen R<2> is C1-C6-alkyl, C1-C6-alkoxy, C3-C8-cycloalkyl, C2-C6-alkenyl, cyano or a heterocyclic residue, which comprises reacting a compound of formula II where R<1> and R<2> are as defined above with a brominating agent in a solvent containing at least 55% by weight of pyridine. 2. Fremgangsmåte ifølge krav 1, hvor bromeringensmiddel som blir anvendt er brom.2. Method according to claim 1, where the brominating agent used is bromine. 3. Fremgangsmåte ifølge krav 1, hvor bromeringensmiddel som blir anvendt er hydrogenbromid og hydrogenperoksyd.3. Process according to claim 1, where the brominating agent used is hydrogen bromide and hydrogen peroxide. 4. Fremgangsmåte ifølge hvilket som helst av kravene 1 - 3, hvor løsningsmidlet som blir anvendt er pyridin.4. Method according to any one of claims 1 - 3, where the solvent used is pyridine. 5. Fremgangsmåte ifølge hvilket som helst av kravene 1-4, hvor R<1> er Ci-Q-alkyl.5. Method according to any one of claims 1-4, where R<1> is C1-Q-alkyl. 6. Fremgangsmåte ifølge krav 5, hvor R<1> er metyl eller etyl.6. Process according to claim 5, where R<1> is methyl or ethyl. 7. Fremgangsmåte ifølge hvilket som helst av kravene 1-6, hvor R<2> er en heterocyklisk ring.7. A method according to any one of claims 1-6, wherein R<2> is a heterocyclic ring. 8. Fremgangsmåte ifølge krav 7, hvor R2 er en isoksazol, isoksaizolin eller isoksazolidinring.8. Method according to claim 7, where R 2 is an isoxazole, isoxaisoline or isoxazolidine ring. 9. Fremgangsmåte ifølge krav 8, hvor R2 er 4,5-dihydroisoksazol-3-yl eller 4,5-dihydroisoksazol-5-yl.9. Process according to claim 8, where R 2 is 4,5-dihydroisoxazol-3-yl or 4,5-dihydroisoxazol-5-yl. 10. Fremgangsmåte ifølge hvilket som helst av kravene 1-8 for fremstilling av 4-brom-2-(4,5-dihydroisoksazol-3-yl)-3-metylanilin.10. Process according to any one of claims 1-8 for the production of 4-bromo-2-(4,5-dihydroisoxazol-3-yl)-3-methylaniline.
NO20026201A 2000-06-30 2002-12-23 Process for the preparation of 4-bromo-aniline derivatives NO324408B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10030975 2000-06-30
PCT/EP2001/007482 WO2002002537A1 (en) 2000-06-30 2001-06-29 Method for producing 4-bromine-aniline derivatives

Publications (3)

Publication Number Publication Date
NO20026201D0 NO20026201D0 (en) 2002-12-23
NO20026201L NO20026201L (en) 2002-12-23
NO324408B1 true NO324408B1 (en) 2007-10-08

Family

ID=7646770

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026201A NO324408B1 (en) 2000-06-30 2002-12-23 Process for the preparation of 4-bromo-aniline derivatives

Country Status (22)

Country Link
EP (1) EP1296965B1 (en)
JP (1) JP4937485B2 (en)
KR (1) KR100779315B1 (en)
CN (1) CN1182124C (en)
AT (1) ATE305928T1 (en)
AU (2) AU2001269111B2 (en)
BR (1) BRPI0112121B1 (en)
CA (1) CA2413723C (en)
CZ (1) CZ301413B6 (en)
DE (1) DE50107619D1 (en)
DK (1) DK1296965T3 (en)
EA (1) EA006293B1 (en)
ES (1) ES2250425T3 (en)
HU (1) HUP0301741A3 (en)
IL (2) IL153412A0 (en)
MX (1) MXPA02012483A (en)
NO (1) NO324408B1 (en)
NZ (1) NZ523825A (en)
PL (1) PL206026B1 (en)
SK (1) SK285627B6 (en)
WO (1) WO2002002537A1 (en)
ZA (1) ZA200300816B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143819A1 (en) * 2010-05-19 2011-11-24 Rhodia (China) Co., Ltd. Process for preparing an ortho-substituted 5-halophenol and a synthesis intermediate thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6377844A (en) * 1986-09-18 1988-04-08 Nippon Kayaku Co Ltd Production of p-bromoanilines
JPH0816085B2 (en) * 1988-06-07 1996-02-21 日本化薬株式会社 Method for producing 2-bromo-4-fluoroaniline
IL108630A0 (en) * 1993-02-18 1994-05-30 Fmc Corp Insecticidal substituted 2,4-diaminoquinazolines
WO1998008785A1 (en) * 1996-08-30 1998-03-05 Aventis Research & Technologies Gmbh & Co Kg Bromination of aromatic compounds with ozone
EA009301B1 (en) * 1998-05-11 2007-12-28 Басф Акциенгезельшафт A process for preparing thioethers and use thereof

Also Published As

Publication number Publication date
WO2002002537A1 (en) 2002-01-10
SK285627B6 (en) 2007-05-03
KR100779315B1 (en) 2007-11-27
BRPI0112121B1 (en) 2015-09-01
SK17972002A3 (en) 2003-06-03
DE50107619D1 (en) 2006-02-16
ATE305928T1 (en) 2005-10-15
JP4937485B2 (en) 2012-05-23
AU2001269111B2 (en) 2006-12-14
NO20026201D0 (en) 2002-12-23
CA2413723C (en) 2010-01-12
MXPA02012483A (en) 2003-04-25
PL359155A1 (en) 2004-08-23
BR0112121A (en) 2003-05-13
EP1296965A1 (en) 2003-04-02
CN1438995A (en) 2003-08-27
EA006293B1 (en) 2005-10-27
NO20026201L (en) 2002-12-23
EP1296965B1 (en) 2005-10-05
IL153412A0 (en) 2003-07-06
CZ20024177A3 (en) 2003-05-14
ZA200300816B (en) 2004-03-10
ES2250425T3 (en) 2006-04-16
HUP0301741A3 (en) 2005-01-28
JP2004502680A (en) 2004-01-29
KR20030014393A (en) 2003-02-17
DK1296965T3 (en) 2005-12-12
IL153412A (en) 2008-04-13
AU6911101A (en) 2002-01-14
CA2413723A1 (en) 2002-12-20
NZ523825A (en) 2004-06-25
CN1182124C (en) 2004-12-29
EA200300012A1 (en) 2003-04-24
HUP0301741A2 (en) 2003-08-28
PL206026B1 (en) 2010-06-30
CZ301413B6 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
KR100604302B1 (en) Method For Producing Isoxazoline-3-yl-acyl Benzene
AU2001287633B2 (en) Preparation of 4-thioalkylbromobenzene derivatives
AU2001287633A1 (en) Preparation of 4-thioalkylbromobenzene derivatives
TW201116519A (en) Process for preparing aryl-substituted pyrazoles
CA2413723C (en) Method for producing 4-bromine-aniline derivatives
US6388135B1 (en) Preparation of 4-bromoaniline derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees